538 related articles for article (PubMed ID: 32816106)
1. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
[TBL] [Abstract][Full Text] [Related]
2. Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway.
Lei D; Chengcheng L; Xuan Q; Yibing C; Lei W; Hao Y; Xizhi L; Yuan L; Xiaoxing Y; Qian L
Pharmacol Res; 2019 Aug; 146():104320. PubMed ID: 31220559
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TUG1 inhibits the proliferation and fibrosis of mesangial cells in diabetic nephropathy via inhibiting the PI3K/AKT pathway.
Zang XJ; Li L; Du X; Yang B; Mei CL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7519-7525. PubMed ID: 31539141
[TBL] [Abstract][Full Text] [Related]
4. Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy.
Choi S; Hong SP; Bae JH; Suh SH; Bae H; Kang KP; Lee HJ; Koh GY
J Am Soc Nephrol; 2023 May; 34(5):809-828. PubMed ID: 36724799
[TBL] [Abstract][Full Text] [Related]
5. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
6. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
7. Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy.
Bian Y; Shi C; Song S; Mu L; Wu M; Qiu D; Dong J; Zhang W; Yuan C; Wang D; Zhou Z; Dong X; Shi Y
Cell Tissue Res; 2022 Oct; 390(1):93-112. PubMed ID: 35821438
[TBL] [Abstract][Full Text] [Related]
8. XBP1 inhibits mesangial cell apoptosis in response to oxidative stress via the PTEN/AKT pathway in diabetic nephropathy.
Wang Y; He Z; Yang Q; Zhou G
FEBS Open Bio; 2019 Jul; 9(7):1249-1258. PubMed ID: 31077568
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.
Zhang Z; Peng H; Chen J; Chen X; Han F; Xu X; He X; Yan N
FEBS Lett; 2009 Jun; 583(12):2009-14. PubMed ID: 19450585
[TBL] [Abstract][Full Text] [Related]
10. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
[TBL] [Abstract][Full Text] [Related]
11. AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway.
Shemesh II; Rozen-Zvi B; Kalechman Y; Gafter U; Sredni B
PLoS One; 2014; 9(12):e114287. PubMed ID: 25474550
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy.
Das F; Ghosh-Choudhury N; Mariappan MM; Kasinath BS; Choudhury GG
Am J Physiol Cell Physiol; 2016 Apr; 310(7):C583-96. PubMed ID: 26739493
[TBL] [Abstract][Full Text] [Related]
13. Silencing of PAQR3 suppresses extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via PI3K/AKT signaling pathway.
Li H; Wang Y; Chen B; Shi J
Eur J Pharmacol; 2018 Aug; 832():50-55. PubMed ID: 29787774
[TBL] [Abstract][Full Text] [Related]
14. FBXW7 mediates high glucose‑induced SREBP‑1 expression in renal tubular cells of diabetic nephropathy under PI3K/Akt pathway regulation.
Li L; Yang J; Li F; Gao F; Zhu L; Hao J
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537812
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
16. A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice.
Shu Z; Gao Y; Zhang G; Zhou Y; Cao J; Wan D; Zhu X; Xiong W
J Cell Mol Med; 2019 May; 23(5):3616-3628. PubMed ID: 30821074
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L
PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway.
Huang S; Xu Y; Ge X; Xu B; Peng W; Jiang X; Shen L; Xia L
J Cell Physiol; 2019 Jul; 234(7):11200-11207. PubMed ID: 30515796
[TBL] [Abstract][Full Text] [Related]
19. PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.
Wu D; Peng F; Zhang B; Ingram AJ; Kelly DJ; Gilbert RE; Gao B; Krepinsky JC
J Am Soc Nephrol; 2009 Mar; 20(3):554-66. PubMed ID: 19211711
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy.
Chen K; Yu B; Liao J
Mol Med; 2021 Jul; 27(1):71. PubMed ID: 34238205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
